DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced the country’s first Echosens FibroScan® Expert ...

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to ...

Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in MASH diagnosis and care.

This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

By combining their diagnostic and therapeutic expertise, Echosens and Boehringer Ingelheim aim to help close persistent gaps ...

As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of ...

DIMO Healthcare has introduced the country’s first Echosens FibroScan Expert 630, revolutionizing non-invasive liver assessments. This innovative technology, which is acknowledged as the world ...

DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced the country’s first Echosens FibroScan® Expert 630, revolutionizing non-invasive liver assessments. This innovative ...

JVL acknowledges a grant to ISGlobal to support this work from Novo Nordisk and Echosens. He also acknowledges grants to ISGlobal from AbbVie, Boehringer Ingelheim, Echosens, Gilead Sciences, Madrigal ...

The agency managing the federal government’s health IT efforts has a new leader, a spokesperson for the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT ...